# Effect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 Infection

> **NCT04508439** · NA · UNKNOWN · sponsor: **Hospital Regional de Alta especialidad de Ixtapaluca** · enrollment: 130 (estimated)

## Conditions studied

- Covid19
- Pneumonia
- Coagulation Disorder
- Pulmonary Embolism

## Interventions

- **DRUG:** Enoxaparin

## Key facts

- **NCT ID:** NCT04508439
- **Lead sponsor:** Hospital Regional de Alta especialidad de Ixtapaluca
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-20
- **Primary completion:** 2020-08-30
- **Final completion:** 2020-12-30
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2020-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04508439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04508439, "Effect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 Infection". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT04508439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*